Inventor · disambiguated record
Neil Buckley
Also filed as: BUCKLEY NEIL · BUCKLEY NEIL F
11 granted patents·3 pending applications·71 citations·filing 1993–2024
88Inventor score
Files withIMBRIA PHARMACEUTICALS INC7ATHENEN THERAPEUTICS INC2BRISTOL MYERS SQUIBB CO1BUCKLEY NEIL F1CISCO TECH INC1
Top patents by PatentIndex Score
14 records- 0191US11090314B2Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereofATHENEN THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·3 cites·14 claims
- 0290US11571432B2Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereofELIEM THERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·2 cites·10 claims
- 0388US10857163B1Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereofATHENEN THERAPEUTICS INC·Filed 2019·Granted Dec 8, 2020·3 cites·8 claims
- 0482US11780811B2Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Oct 10, 2023·1 cites·21 claims
- 0582US11530184B2Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·22 claims
- 0679US9026405B2Systems and methods for home energy auditingBUCKLEY NEIL F·Filed 2012·Granted May 5, 2015·9 cites·24 claims
- 0778US12065410B2Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Aug 20, 2024·0 cites·25 claims
- 0878US11746090B2Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2022·Granted Sep 5, 2023·0 cites·25 claims
- 0977US2025074878A1Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1076US12110275B2Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 1176US2023147799A1Compositions that preferentially potentiate subtypes of gabaa receptors and methods of use thereofELIEM THERAPEUTICS UK LTD·Filed 2022·Application pending·0 cites
- 1274US2024383857A1Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1361US8347214B2Automated interface-specification generation for enterprise architecturesCISCO TECH INC·Filed 2006·Granted Jan 1, 2013·6 cites·17 claims
- 1443US5507748AAcetabular prosthetic apparatus and techniquesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Apr 16, 1996·46 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Neil Buckley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →